Tag | Content |
---|
EnhancerAtlas ID | HS139-17285 |
Organism | Homo sapiens |
Tissue/cell | Myotube |
Coordinate | chr14:89849540-89851590 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
EBF1 | MA0154.3 | chr14:89850495-89850509 | AGCCCCAAGGGACT | + | 6 | EWSR1-FLI1 | MA0149.1 | chr14:89849900-89849918 | CCTTCCTTGCCTCCTCCT | - | 6.02 | RORA(var.2) | MA0072.1 | chr14:89850319-89850333 | AATAATTAGGTCAC | + | 6.16 |
|
| Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
SE_10986 | chr14:89847690-89853693 | CD20 | SE_60929 | chr14:89796072-89853493 | DHL6 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 1 | ID | Chromosome | Start | End |
GH14I089383 | chr14 | 89849500 | 89853547 |
|
Enhancer Sequence | AATTGGGAAA ATGAGCTTTT ATCAATGTCT AAATGTTCAC GAACAGGCAG AGAAATGTCA 60 GGTTCTACCA CATGTGACAC GGCAAAAAAG ACATCTTCCA ATGCATGAGG CTTCTCCAGG 120 CAGACATGAA GAGGGACACA CTAGCCTGAT AGAGCAGGCA AAATGACGAC AAAAATCAGA 180 GGTGAGTGTA TTGCACCAAA TTAGGTTGGT GCAAAAATAA TTGCAGTTTT TGCCATTACT 240 TTCAATAGTT TCCCAGAGCT GCCATCACAA ATTAACACAA ACTTGGTGGC TTAAATCAAC 300 AGAAATTCTC TCACAGACCA GAAGTGTGAA ATCAAGGAGC CGACAGGACC TGGGGAACAT 360 CCTTCCTTGC CTCCTCCTGG CTTCTGGCGG CCCCCGGCCG ATCTTGGCAC TCCCTGGCTC 420 ACCCCTGCAT TGGTCCAGTC TCTTCCTGTG TCATCTTCCC CACGTATCTG TTTCCTTTCC 480 TCTCCTCTCC TCTCCTCGTA AGGGACGCTA GTCAATGACT TCAGAGCCCA CTCAAATCCA 540 TTCTGACCTC ATCTTAACCA ATTACATCTG CAAAAACCCT ATTTTTATTT TTATGTATTC 600 ATTTTTTTTT TTGAGAAGAG TCTTGCTCTG TCGCCCAGGG TGGAGTGCAA TGGTGCGATC 660 TCAGCTGACT GCAAACTCTG CCTCCCAGGT TCAAGCAATT TTTGTGCCTC GGCCTCCCGA 720 GTAGCTGGAA TTACAGGTGC CCACCACCAT GCCCAGCTAA AAAAAAAATG CTATTTTAAA 780 ATAATTAGGT CACTAAATAA GACTCCAGGT GGACATGAAT TTGGTGGGGG GGGACATTTC 840 AGCCCACTAC AGTGATAACA GAGAACATCA GGGGATATGC TACAATCATT AGAGCTGAAA 900 GAACCTCAAA GGTAACCTTT TCCACAGATG TTAAACAGAC TTCTTCTCTG ATGCCAGCCC 960 CAAGGGACTG GTGGTGGCTT CTGAGAATGG TGCTCACAGA AGCAGCTGAG GATGACAGCT 1020 GTGGCCAGCG ATGGATGGCT GCCCTGGGCG TGGCATGTGG GAGAGGAGAT CAACTCCTCA 1080 CCTCTGCGCC CACCAGCCTG CTTCACTGTG CTCACTTTGC AGATATAGAA ACTAAGCCTG 1140 TGAAATGCTG AAGTGATAGT TCTACTTAGT GGAAGAATCA GGACCAGAAC CCAAGTCTCC 1200 TGAGTCTGCA TCTGACAACC AGCTCTTCTA ATACGTACCA GGAACATACA ATTCTGAGTC 1260 ACAGACAAGC TACTTACTAT GGGCAGACAC TAAAAAACAA CTAATGACTT TCATTCATAT 1320 AACATGGTTT CATCCACTTG GAAAACTGTT TTTGTAATCT AGATTAAAAA AAACTTCCTT 1380 TCTTCAACAA ACATCAGCCC CACACCTACC ACAATACCAG GAATGAGTCC TAGGAATACC 1440 TCATCTAGTT GTAAAAATAT ATATATAAAG CAATACAGAG ATGCAGAGAT AAAAATAAGC 1500 CCTGTCTTAT GGTTCCACTG AGAAGAGGGA CATGACCCAG CCTGAGCAGG GAGAATCATG 1560 GCAGACTTCT TGGAGGCGAT GATGGCTGTC AAAGTCTACA GGATGAACAG GCCTTAGCTA 1620 GGGGCAGAGA AGGATAAGGT CATGACTAAT GGCAGGAACA ACAGCCTTGA TGGCTCTCTG 1680 AACTGGAGCT AAGGTTGCTG TACGTGTTGT AAATTACATG GTTTTATATC CCATGGAGAA 1740 ACAGCCTTAC AATGAAATCT TTTTATAAAC TTGCACCTGG AGATTATGTC TCTCCCCTAA 1800 GTCGGCATCT TACCAGGGAA GGAGAATTAT GGAATCTGCC GAGTTTCCAT TTTTGCCTTG 1860 GCTGTCAGGC ACTCAATCAC AACAAATATA TTAGGTCAAG AATTTGGAAT ATTTGCTTTC 1920 CCCTCTCTCT ACTGCATTTG TCTATTTTCA ATTTTTACCT TAGCGACCTG ATTGTGACCT 1980 ATATGTCTTA TGGCAAGCCC TATGAAAAGG AAGTGGGGTA TAAATTATAA ATGTGCCAAT 2040 AAAGAATACT 2050
|